Connect with us

Geodon (ziprasidone)

Ziprasidone (or GEODON®) is mainly prescribed to treat schizophrenia and bipolar disorder.

Status: ACTIVE

Class: Atypical (AAP)

FDA Approval: 2001

Dosage Forms: 20 mg, 40 mg, 60 mg, 80 mg

Biological Half-life: 7-10 hours

Side Effects: Dizziness, headache, hypersalivation/dry mouth, weight gain, movement problems

Routes of Administration: Oral, IM

Pregnancy Category: C (US)

  www.geodon.com

Advertisement

© 2018 Mental Daily. All Rights Reserved.
Our content is for informational purposes and should not be used as medical or treatment recommendation.